A Pivotal Study to Evaluate the Safety and Effectiveness of RMT Medical Technology's SafeFlo® Vena Cava Filter - Contacts and Locations

A Pivotal Study to Evaluate the Safety and Effectiveness of RMT Medical Technology's SafeFlo® Vena Cava Filter

This study is ongoing, but not recruiting participants.

Study NCT00654979. Last updated on April 3, 2008. Information provided by RMT Medical Technologies, Ltd.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00654979

Locations


United States, New Jersey
	Holy Name Hospital
	Teaneck, New Jersey, United States

United States, New York
	Montefiore Medical Center
	Bronx, New York, United States
	Mt. Sinai Hospital
	Manhattan, New York, United States

Austria
	University Hospital Vienna
	Vienna, Austria

Greece
	251 Air Force Hospital
	Athens, Greece

Israel
	Rabin Medical Center
	Petach Tikva, Israel

South Africa
	Universitas Hospital
	Bloemfontein, South Africa

United Kingdom, Scotland
	Queen Margaret Hospital
	Dumfermline, Scotland, United Kingdom

Sponsors and Collaborators

RMT Medical Technologies, Ltd.